Clinical Trial Update: Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on maximal suppression of the androgen axis in clinically localized prostate cancer. The study is completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Washington | Conditions: Cancer, Prostate Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2017-05-08